Poster will feature RNA primed SMAR-T™ cells against multiple cancer driver mutations NATICK, Mass., April 14, 2023 /PRNewswire/ — Geneius Biotechnology, Inc., an immuno-oncology company developing a best-in-class personalized RNA-enabled T cell therapy platform that generates a robust…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.